PERSONAL INFORMATION
Name: Zhou Dong
Gender: Male
Title: Chief Physician
Position: Deputy Director，Department of Cardiovascular
Medicine, Yongchuan Hospital of Chongqing Medical University.
CONTACT INFORMATION
Email: zhoudong8587@126.com
Address: No. 439 Xuanhua Road, Yongchuan District, Yongchuan Hospital of Chongqing Medical University, China
Phone: +86-15823325860
EDUCATION EXPERIENCE
1998.8 - 2003.7 Clinical Medicine, Bachelor, Xi’an Jiaotong University.
2005.8- 2008.7 Cardiovascular Medicine, Master, Kunming Medical University.
2012.9- 2016.3 Cardiovascular Medicine, M D, Xi’an Jiaotong University.
WORKING EXPERIENCE
2023.02 to now, Deputy Director，Department of Cardiovascular Medicine, Yongchuan Hospital of Chongqing Medical University.
2022.09-2023.01, Director，Department of Cardiovascular Medicine, the Sanerlingyi Affiliated Hospital of Xi’an Jiaotong University.
2021.09-2022.08, Associate Dean ,The Fourth People's Hospital of Shaanxi Province.
2018.08-2022.08, Deputy Director，Department of Cardiovascular Medicine, the Sanerlingyi Affiliated Hospital of Xi’an Jiaotong University.
2008.07- 2012.08 Associate chief and attending doctor, Department of Cardiovascular Medicine, Sanerlingyi Hospital.
RESEARCH INTERESTS
Dr. Zhou’s interests concentrate on the treatment and the scientific research of critical cardiovascular diseases. In the past few decades, cardiovascular disease has been the leading cause of population death. Early warning and reasonable treatment of the disease are the most effective ways to solve this problem. Dr. Zhou led his team to significantly improve the efficiency of cardiovascular disease treatment through the establishment of national level chest pain center, heart failure center and atrial fibrillation center. On the other hand, Dr. Zhou has focused on the research of atherosclerosis pathogenesis for many years, and promoted the scientific research and teaching of cardiovascular diseases. Another research area of Dr. Zhou is to establish a cardiovascular disease clinical risk assessment system. In recent years, his team has identified numerous risk factors for poor cardiovascular prognosis and established a risk assessment model based on those studies. These research outputs were published in top journals in the field, including Journal of Translational Medicine, The FASEB Journal, etc.
HONOUR & AWARDS
National Committee Member, the Cardiovascular Branch of China Association of Chinese Medicine.
Committee Member, the Internal Medicine Branch of Chongqing Medical Association.
Vice Chairman , Hanzhong Atrial Fibrillation Center Alliance.
Committee Member, the Cardiovascular Branch of Shaanxi International Medical Exchange Promotion Association.
Youth Committee Member, the Cardiovascular Disease Branch of Shaanxi Medical Association.
PUBLICATIONS
1. Qiao X, Zheng T, Xie Y, Yao X, Yuan Z, Wu Y, Zhou D* & Chen, T*. MiR-146a rs2910164 (G/C) polymorphism is associated with the development and prognosis of acute coronary syndromes: an observational study including case control and validation cohort. Journal of Translational Medicine, 21(1), 325.
2. Zhang Y, Wang Y, Zhou D, et al. Angiotensin II deteriorates advanced atherosclerosis by promoting MerTK cleavage and impairing efferocytosis through the AT1R/ROS/p38 MAPK/ADAM17 pathway[J]. American Journal of Physiology-Cell Physiology, 2019, 317(4): C776-C787.
3. Zhao Q, Zhou D, You H, et al. IFN-γ aggravates neointimal hyperplasia by inducing endoplasmic reticulum stress and apoptosis in macrophages by promoting ubiquitin-dependent liver X receptor-α degradation[J]. The FASEB Journal, 2017: fj. 201700327R(SCI IF: 5.5).
4. Zhou D, Wang X, Chen T, et al. The NLRP3 rs10754558 polymorphism is associated with the occurrence and prognosis of coronary artery disease in the Chinese Han Population[J]. BioMed research international, 2016, 2016: 3185397.
5. Zhou D, Fan Y, Wan Z, et al. Platelet-to-Lymphocyte Ratio Improves the Predictive Power of GRACE Risk Score for Long-Term Cardiovascular Events in Patients with Acute Coronary Syndrome[J]. Cardiology, 2016, 134(1): 39-46.
6. Zhou D, Wan Z, Fan Y, et al. A combination of the neutrophil-to-lymphocyte ratio and the GRACE risk score better predicts PCI outcomes in Chinese Han patients with acute coronary syndrome[J]. Anatol J Cardiol, 2015, 15(12): 995-1001.
7. Zhou D, Zhou J, Wan Z, et al. Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population[J]. Experimental and Therapeutic Medicine, 2017, 13(2): 731-738.
8. Zhou D, Zhou J, Wan Z, et al. GW25-e5395 The Association of miR-146a, miR-125a, and miR-34b/c Polymorphisms With Coronary Artery Disease and Acute Myocardial Infarction Risk. Journal of the American College of Cardiology 2014; 64(16_S)
9. Wan Z F, Zhou D, Xue J H, et al. Combination of mean platelet volume and the GRACE risk score better predicts future cardiovascular events in patients with acute coronary syndrome[J]. Platelets, 2014, 25(6): 447-451.
